See All Slides - tctmd.com

Slides

Presentation TCT 2014

Impact of Ischemic Post-Conditioning on Infarct Size and Clinical Outcomes in Primary Percutaneous Coronary Intervention: A Meta-analysis of 26 Randomized Controlled Trials

Presenter: Alok Saurav

September 16, 2014

Presentation TCT 2014

Tongxinluo reduces infarct size by promoting endothelial adhesion junction integrity in reperfused diabetic hearts via PPAR-? pathway

Presenter: Kang Qi

September 16, 2014

Presentation TCT 2014

Prediction of the True Fractional Flow Reserve of Left Main Coronary Artery Stenosis with Concomitant Downstream Stenoses: in vitro and in vivo Experiments_

Presenter: Erika Yamamoto

September 16, 2014

Presentation TCT 2014

Transcatheter pulmonary valve replacement with the Edwards-Sapien Valve: The Toronto Congenital Cardiac Centre for Adults Experience

Presenter: William Wilson

September 16, 2014

Presentation TCT 2014

Safety and Effectiveness of Prasugrel vs_ Clopidogrel in the Setting of Bivalirudin vs_ Heparin Use: 30-day Results from TRANSLATE-ACS

Presenter: Timothy Henry

September 16, 2014

Presentation TCT 2014

Can we improve the diagnostic efficacy of angiography and intravascular ultrasound in assessing intermediate lesions?

Presenter: Slawomir Golebiewski

September 16, 2014

Presentation TCT 2014

Evaluation of flow reversal during carotid artery stenting as the first choice for embolic protection - no contraindications!

Presenter: Marius Hornung

September 16, 2014

Presentation TCT 2014

Analysis of Quality of Life Decrements Associated with Changes in Angina Status in the ABSORB II Trial: First Randomized Comparison Between the Absorb? Everolimus Eluting___

Presenter: Bernard Chevalier

September 16, 2014

Presentation TCT 2014

Coarctation Stenting Through the Carotid Approach in Neonates and Infants_

Presenter: Carlos Pedra

September 16, 2014

Presentation TCT 2014

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent in patients undergoing primary percutaneous coronary intervention: 3 Year___

Presenter: Georgios Vlachojannis

September 16, 2014

Advertisement

Slides

Impact of Ischemic Post-Conditioning on Infarct Size and Clinical Outcomes in Primary Percutaneous Coronary Intervention: A Meta-analysis of 26 Randomized Controlled Trials

Tongxinluo reduces infarct size by promoting endothelial adhesion junction integrity in reperfused diabetic hearts via PPAR-? pathway

Prediction of the True Fractional Flow Reserve of Left Main Coronary Artery Stenosis with Concomitant Downstream Stenoses: in vitro and in vivo Experiments_

Transcatheter pulmonary valve replacement with the Edwards-Sapien Valve: The Toronto Congenital Cardiac Centre for Adults Experience

Safety and Effectiveness of Prasugrel vs_ Clopidogrel in the Setting of Bivalirudin vs_ Heparin Use: 30-day Results from TRANSLATE-ACS

Can we improve the diagnostic efficacy of angiography and intravascular ultrasound in assessing intermediate lesions?

Evaluation of flow reversal during carotid artery stenting as the first choice for embolic protection - no contraindications!

Analysis of Quality of Life Decrements Associated with Changes in Angina Status in the ABSORB II Trial: First Randomized Comparison Between the Absorb? Everolimus Eluting___

Coarctation Stenting Through the Carotid Approach in Neonates and Infants_

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent in patients undergoing primary percutaneous coronary intervention: 3 Year___

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content